These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7692418)

  • 1. Electrophysiological evaluation of moricizine in patients with sustained ventricular tachyarrhythmias: low efficacy and high incidence of proarrhythmia.
    Bhandari AK; Lerman R; Ehrlich S; Sager P; Leon C; Widerhorn J; Cannom DS
    Pacing Clin Electrophysiol; 1993 Sep; 16(9):1853-61. PubMed ID: 7692418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and risks of moricizine in inducible sustained ventricular tachycardia.
    Damle R; Levine J; Matos J; Greenberg S; Brooks R; Frumkin W; Goldberger J; Kadish AH
    Ann Intern Med; 1992 Mar; 116(5):375-81. PubMed ID: 1736770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioversion, defibrillation, and overdrive pacing of ventricular arrhythmias: the effect of moricizine in dogs with sustained monomorphic ventricular tachycardia.
    Avitall B; Hare J; Zander G; Lessila C; Dhala A; Deshpande S; Jazayeri M; Sra J; Akhtar M
    Pacing Clin Electrophysiol; 1993 Nov; 16(11):2092-7. PubMed ID: 7505920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic response to moricizine in patients with sustained ventricular arrhythmias.
    Powell AC; Gold MR; Brooks R; Garan H; Ruskin JN; McGovern BA
    Ann Intern Med; 1992 Mar; 116(5):382-7. PubMed ID: 1736771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of proarrhythmic events during moricizine therapy and their relationship to ventricular function.
    Tschaidse O; Graboys TB; Lown B; Lampert S; Ravid S
    Am Heart J; 1992 Oct; 124(4):912-6. PubMed ID: 1529903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moricizine-induced proarrhythmia.
    Seaborg SM; Cowan MD
    Clin Cardiol; 1992 Nov; 15(11):866-7. PubMed ID: 10969633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of nonsustained ventricular tachycardia guided by electrophysiological testing.
    Kadish A; Schmaltz S; Calkins H; Morady F
    Pacing Clin Electrophysiol; 1993 May; 16(5 Pt 1):1037-50. PubMed ID: 7685883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise induced fatal sinusoidal ventricular tachycardia secondary to moricizine.
    Nazari J; Bauman J; Pham T; Ivanovich L; Kehoe RF
    Pacing Clin Electrophysiol; 1992 Oct; 15(10 Pt 1):1421-4. PubMed ID: 1383951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of moricizine in malignant ventricular arrhythmias.
    Horowitz LN
    Am J Cardiol; 1990 Feb; 65(8):41D-46D; discussion 68D-71D. PubMed ID: 1689535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia.
    Wyndham CR; Pratt CM; Mann DE; Winkle RA; Somberg J; de Maria AN; Josephson ME
    Am J Cardiol; 1987 Oct; 60(11):67F-72F. PubMed ID: 3310588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents.
    Kehoe RF; MacNeil DJ; Zheutlin TA; Ezri MD; Nazari J; Spangenberg RB; Dunnington C; Lueken M
    Am J Cardiol; 1993 Aug; 72(4):56A-66A. PubMed ID: 8346728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethmozine: electrophysiology, hemodynamics, and antiarrhythmic efficacy in patients with life-threatening ventricular arrhythmias.
    Dorian P; Echt DS; Mead RH; Lee JT; Lebsack CS; Winkle RA
    Am Heart J; 1986 Aug; 112(2):327-33. PubMed ID: 3526852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moricizine concentration to guide arrhythmia treatment: with attention to elderly patients.
    Giardina EG; Wechsler ME; Dolgopiatova M; Sciacca R
    J Clin Pharmacol; 1994 Jul; 34(7):725-33. PubMed ID: 7523457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmias.
    Hession MJ; Lampert S; Podrid PJ; Lown B
    Am J Cardiol; 1987 Oct; 60(11):59F-66F. PubMed ID: 3310587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proarrhythmia in patients treated with moricizine.
    Ellenbogen KA; Welch WJ; Schoenfeld MH
    Pacing Clin Electrophysiol; 1992 Sep; 15(9):1240-3. PubMed ID: 1383982
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
    Martínez-Rubio A; Shenasa M; Chen X; Wichter T; Breithardt G; Borggrefe M
    Am J Cardiol; 1994 Feb; 73(5):357-60. PubMed ID: 7509121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of coronary artery bypass grafting on ventricular arrhythmias: results with electrophysiological testing and long-term follow-up.
    Manolis AS; Rastegar H; Estes NA
    Pacing Clin Electrophysiol; 1993 May; 16(5 Pt 1):984-91. PubMed ID: 7685898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and characteristics of proarrhythmia from moricizine (Ethmozine).
    Morganroth J; Pratt CM
    Am J Cardiol; 1989 Jan; 63(3):172-6. PubMed ID: 2642632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of oral quinidine-mexiletine combination therapy for sustained ventricular tachyarrhythmias as assessed by programmed electrical stimulation when quinidine monotherapy has failed.
    Bonavita GJ; Pires LA; Wagshal AB; Cuello C; Mittleman RS; Greene TO; Huang SK
    Am Heart J; 1994 Apr; 127(4 Pt 1):847-51. PubMed ID: 8154423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.
    Kühlkamp V; Mermi J; Mewis C; Seipel L
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):373-81. PubMed ID: 9125676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.